12-102866597-G-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP4PP3PS3PM3_Strong
This summary comes from the ClinGen Evidence Repository: The c.508C>G (p.His170Asp) variant in PAH has been reported in 1 patient with hyperphenylalaninemia, and 1 patient with benign persistent hyperphenylalaninemia. (PP4; PMID:11385716). This variant has an extremely low allele frequency (0.00018) in gnomAD (PM2; http://gnomad.broadinstitute.org). This variant has 43% enzyme activity (PS3; PMID:17935162). This variant was detected in trans with R261X, c.60+5G>T, c.1315+1G>A (Pathogenic in ClinVar) (PM3_Strong; PMID:11385716; PMID:24941924). Computational prediction tools and conservation analysis suggest that the c.829T>G variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PS3, PM3_Strong LINK:https://erepo.genome.network/evrepo/ui/classification/CA273111/MONDO:0009861/006
Frequency
Consequence
NM_000277.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAH | NM_000277.3 | c.508C>G | p.His170Asp | missense_variant, splice_region_variant | Exon 5 of 13 | ENST00000553106.6 | NP_000268.1 | |
PAH | NM_001354304.2 | c.508C>G | p.His170Asp | missense_variant, splice_region_variant | Exon 6 of 14 | NP_001341233.1 | ||
PAH | XM_017019370.2 | c.508C>G | p.His170Asp | missense_variant, splice_region_variant | Exon 5 of 7 | XP_016874859.1 | ||
LOC124902999 | XR_007063428.1 | n.807+1370G>C | intron_variant | Intron 1 of 2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAH | ENST00000553106.6 | c.508C>G | p.His170Asp | missense_variant, splice_region_variant | Exon 5 of 13 | 1 | NM_000277.3 | ENSP00000448059.1 | ||
PAH | ENST00000549111.5 | n.604C>G | splice_region_variant, non_coding_transcript_exon_variant | Exon 5 of 6 | 1 | |||||
PAH | ENST00000307000.7 | c.493C>G | p.His165Asp | missense_variant, splice_region_variant | Exon 6 of 14 | 5 | ENSP00000303500.2 | |||
PAH | ENST00000551988.5 | n.530+10865C>G | intron_variant | Intron 4 of 4 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251354Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135838
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459932Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726424
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Phenylketonuria Pathogenic:4
- -
This sequence change replaces histidine, which is basic and polar, with aspartic acid, which is acidic and polar, at codon 170 of the PAH protein (p.His170Asp). This variant is present in population databases (rs199475655, gnomAD 0.01%). This missense change has been observed in individual(s) with benign persistent hyperphenylalaninemia and hyperphenylalaninemia (PMID: 11385716, 12971421). ClinVar contains an entry for this variant (Variation ID: 92744). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects PAH function (PMID: 15557004, 17935162). For these reasons, this variant has been classified as Pathogenic. -
- -
The c.508C>G (p.His170Asp) variant in PAH has been reported in 1 patient with hyperphenylalaninemia, and 1 patient with benign persistent hyperphenylalaninemia. (PP4; PMID: 11385716). This variant has an extremely low allele frequency (0.00018) in gnomAD (PM2; http://gnomad.broadinstitute.org). This variant has 43% enzyme activity (PS3; PMID: 17935162). This variant was detected in trans with R261X, c.60+5G>T, c.1315+1G>A (Pathogenic in ClinVar) (PM3_Strong; PMID: 11385716; PMID: 24941924). Computational prediction tools and conservation analysis suggest that the c.829T>G variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PS3, PM3_Strong -
not provided Pathogenic:2Other:1
- -
- -
The H170D missense variants in the PAH gene has been reported as a pathogenic variant in the PAH Consortium database. The H170D has been reported previously in association with both mild phenylketonuria (PKU) and with hyperphenylalaninemia (Yang et al., 2001; Vela-Amieva et al., 2015). Functional analysis found that H170D is associated with significant residual enzyme activity and is classified as a BH4-responsive variant (Zurfluh et al. 2008). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at